Jo VY - Search Results

1

Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma.

Chau NG, Li YY, Jo VY, Rabinowits G, Lorch JH, Tishler RB, Margalit DN, Schoenfeld JD, Annino DJ, Goguen LA, Thomas T, Becker H, Haddad T, Krane JF, Lindeman NI, Shapiro GI, Haddad RI, Hammerman PS. Chau NG, et al. Among authors: jo vy. Clin Cancer Res. 2016 Jun 15;22(12):2939-49. doi: 10.1158/1078-0432.CCR-15-2314. Epub 2016 Jan 13. Clin Cancer Res. 2016. PMID: 26763254

2

Repeatedly nondiagnostic thyroid fine-needle aspirations do not modify malignancy risk.

Jo VY, Vanderlaan PA, Marqusee E, Krane JF. Jo VY, et al. Acta Cytol. 2011;55(6):539-43. doi: 10.1159/000333230. Epub 2011 Dec 9. Acta Cytol. 2011. PMID: 22156463

3

Cyclin D1 and FADD as biomarkers in head and neck squamous cell carcinoma.

Rasamny JJ, Allak A, Krook KA, Jo VY, Policarpio-Nicolas ML, Sumner HM, Moskaluk CA, Frierson HF Jr, Jameson MJ. Rasamny JJ, et al. Among authors: jo vy. Otolaryngol Head Neck Surg. 2012 Jun;146(6):923-31. doi: 10.1177/0194599811435052. Epub 2012 Feb 8. Otolaryngol Head Neck Surg. 2012. PMID: 22323434

4

Relative sensitivity of thyroid fine-needle aspiration by tumor type and size.

Jo VY, Renshaw AA, Krane JF. Jo VY, et al. Diagn Cytopathol. 2013 Oct;41(10):871-5. doi: 10.1002/dc.22976. Epub 2013 Feb 28. Diagn Cytopathol. 2013. PMID: 23447387

5

Clinically Relevant Molecular Subtypes in Leiomyosarcoma.

Guo X, Jo VY, Mills AM, Zhu SX, Lee CH, Espinosa I, Nucci MR, Varma S, Forgó E, Hastie T, Anderson S, Ganjoo K, Beck AH, West RB, Fletcher CD, van de Rijn M. Guo X, et al. Among authors: jo vy. Clin Cancer Res. 2015 Aug 1;21(15):3501-11. doi: 10.1158/1078-0432.CCR-14-3141. Epub 2015 Apr 20. Clin Cancer Res. 2015. PMID: 25896974 Free PMC article.

6

Usefulness of translocation-associated immunohistochemical stains in the fine-needle aspiration diagnosis of salivary gland neoplasms.

Foo WC, Jo VY, Krane JF. Foo WC, et al. Among authors: jo vy. Cancer Cytopathol. 2016 Jun;124(6):397-405. doi: 10.1002/cncy.21693. Epub 2016 Feb 16. Cancer Cytopathol. 2016. PMID: 26882287 Free article.

7

Distinctive Patterns of CTNNB1 (β-Catenin) Alterations in Salivary Gland Basal Cell Adenoma and Basal Cell Adenocarcinoma.

Jo VY, Sholl LM, Krane JF. Jo VY, et al. Am J Surg Pathol. 2016 Aug;40(8):1143-50. doi: 10.1097/PAS.0000000000000669. Am J Surg Pathol. 2016. PMID: 27259009

8

Preoperative Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: A Prospective Analysis.

Strickland KC, Vivero M, Jo VY, Lowe AC, Hollowell M, Qian X, Wieczorek TJ, French CA, Teot LA, Sadow PM, Alexander EK, Cibas ES, Barletta JA, Krane JF. Strickland KC, et al. Among authors: jo vy. Thyroid. 2016 Oct;26(10):1466-1471. doi: 10.1089/thy.2016.0280. Epub 2016 Sep 8. Thyroid. 2016. PMID: 27457786

9

Recurrent IDH2 R172X mutations in sinonasal undifferentiated carcinoma.

Jo VY, Chau NG, Hornick JL, Krane JF, Sholl LM. Jo VY, et al. Mod Pathol. 2017 May;30(5):650-659. doi: 10.1038/modpathol.2016.239. Epub 2017 Jan 13. Mod Pathol. 2017. PMID: 28084339 Free article.

10

HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma.

Mito JK, Jo VY, Chiosea SI, Dal Cin P, Krane JF. Mito JK, et al. Among authors: jo vy. Histopathology. 2017 Oct;71(4):511-521. doi: 10.1111/his.13246. Epub 2017 Jul 5. Histopathology. 2017. PMID: 28463429

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters